Archive for July, 2010

FARS and FFIRS

In: Main

11 Jul 2010

The now-famous reports from the Institute of Medicine, “To Err is Human” (November 1999) and “Crossing the Quality Chasm” (March 2001), called for a top-down review of the American health care system. The review that these reports call for should include a detailed focus on error-reporting and prevention programs. These types of programs have been [...]

A few months after the new cholesterol guidelines were announced last year, I  went to a free educational luncheon semi-  nar for physicians. It was sponsored by an unrestricted third-party grant from a pharmaceutical company; academic cardiologists from excellent universities made fair-balanced presentations on the subject of cholesterol-lowering drugs.

Evidence-based medicine (EBM) is defined as the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients. The practice of EBM means integrating individual clinical expertise with the best available clinical evidence obtained from systematic research. Much of this evidence comes from the Cochrane Collaboration, which specifies [...]

Speaker: Hugo A. Katus, MD, Professor of Medicine, Universitaets-Klinkenshubeck, Luebeck, Germany.
Meeting Highlights: American College of Cardiology
A subgroup analysis of data from the COPERNICUS (Carvedilol Prospective Randomized Cumulative Survival) trial demonstrated that treatment with the beta blocker carvedilol (Coreg medication, Glaxo SmithKline) is effective and well-tolerated in patients with severe heart failure (HF) symptoms and an [...]

Speaker: Ron Waksman, MD, Clinical Professor of Medicine (Cardiology), Georgetown University School of Medicine, and Associate Director of the Division of Cardiology, Washington Hospital Center, Washington, DC.
Data from a comparison of patient registries of two studies to assess the value of 12 months of therapy with clopidogrel (Plavix generic, Sanofi Synthelabo/Bristol Myers Squibb) in patients [...]

Aldosterone Blocker in Diabetic Hypertensive Proteinuria
Speaker: Murray Epstein, MD, Professor of Medicine, Nephrology and Hypertension, University of Miami School of Medicine, Miami, Florida.
Eplerenone (Pharmacia), the first selective aldosterone blocker, provided substantial reduction in proteinuria in hypertensive patients with diabetes, compared to the ACE-inhibitor enalapril (Vasotec drug, Merck), with the two together being even more effective [...]

The results of this study indicate that switching patients from amlodipine to either generic felodipine ER or nifedipine CC resulted in the expected reduction in acquisition costs for DHPs, but a significant increase in the overall cost of therapy for patients with hypertension or hypertension and angina. This rise in the overall cost of therapy [...]

Pages: 1 2 Next

About this blog

Blog invites submissions of review articles, reports on clinical techniques, case reports, conference summaries, and articles of opinion pertinent to the control of pain and anxiety in dentistry.

Photostream

    IMG_3265
    Split Rock
    Woman at work--physician
    Ibuprofen to the Rescue [33/366]
    Elms and Biodiversity
    Placebo
    Elderberry Syrup
    condurango
    maltoleum
  • Shelby Miller: Hi, i'm doing a project called History day. The theme is innovation in history and I choose Anesthes [...]
  • Tim Tav: For newly qualified dentists it may help to join firms with a training department that may help to s [...]
  • Prierien: Great. Now I can say thank you! [...]
  • Mark: I bookmarked this link. Thank you for good job! [...]
  • Robor: Hi, Thank you! I would now go on this blog every day! Robor [...]

Tags